Oferlod Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Deferiprone

Indications/Uses

Fe overload in patients w/ thalassemia major when deferoxamine therapy is contraindicated or inadequate.

Dosage/Direction for Use

25 mg/kg 3 times daily.

Administration

Should be taken with food.

Contraindications

Neutropenia & agranulocytosis. Pregnancy & lactation.

Special Precautions

Monitor neutrophil count wkly. Immunocompromised patients. Discontinue therapy if serum ferritin <500 mcg/L. Renal or hepatic impairment; liver fibrosis.

Adverse Reactions

Reddish/brown urine, nausea, abdominal pain, vomiting, arthralgia, increased liver enzymes, neutropenia, increased appetite, diarrhea, agranulocytosis.

View ADR Monitoring Form

Drug Interactions

Trivalent cation products eg, Al-based antacids; vit C.

MIMS Class

Antidotes & Detoxifying Agents

ATC Classification

V03AC02 - deferiprone ; Belongs to the class of iron chelating agents. Used in iron overload.

Regulatory Classification

Presentation/Packing

Form

Oferlod tab 500 mg

Packing/Price

1 × 50's (Rp750,000/boks)

Oferlod

deferiprone

Manufacturer:

Novell Pharma

Marketer:

Novell Pharma